Zetagen Therapeutics Announces Successful Completion of Enrollment in Phase 2a Clinical Study of ZetaMet™ (Zeta-BC-003) Metastatic Breast Cancer
(690,000 patients annually are diagnosed with metastatic lytic bone lesions with only non-curative, palliative therapies available)
Article content
Article content
ZetaMet™ (Zeta-BC-003) is a first-of-its kind molecular pathway designed to resolve metastatic cancer lesions, inhibit pain, and regenerate bone
Phase 2a study examines the safety and efficacy of ZetaMet™ (Zeta-BC-003) for the treatment of metastatic bone lesions to the spine in Stage 4 breast cancer patients
ZetaMet™ (Zeta-BC-003) has the potential to be a curative treatment, without systemic limitations, for metastatic lytic breast cancer lesions to bone
Article content
SYRACUSE, N.Y. — Zetagen Therapeutics, Inc., a private, clinical stage, biopharmaceutical company focused on developing breakthrough therapies, via local administration, for metastatic and primary breast cancers, announced today they have successfully completed enrollment in their phase 2a study, which will evaluate ZetaMet™ (Zeta-BC-003) in the treatment of spinal metastatic lytic breast cancer lesions (ClinicalTrials.gov #NCT05280067).
Article content
'We are excited to reach another critical milestone in the development of ZetaMet™ (Zeta-BC-003),' said Joe C. Loy, Zetagen's Chief Executive Officer. 'We launched this study with stage IV breast cancer patients suffering from spinal metastases, because we recognize their severe pain and how debilitating it is, and that current treatments remain largely palliative. Our objective with ZetaMet™ is to eliminate cancer cells responsible for bone destruction, alleviate pain, stimulate the regeneration of bone lost to lytic lesions, enhance overall quality of life, while improving survival rates.'
Article content
The 26-week study, conducted at the University of British Columbia, (UBC) Vancouver, BC, Canada, will evaluate the safety and efficacy of ZetaMet™ (Zeta-BC-003) in treating vertebral bone defects created by lytic metastatic breast cancer. The study will measure the reduction of skeletal related events (SRE), pain, change in vertebral body defect size, and postoperative prescribed opioid use. The Company anticipates reporting top-line results early fourth quarter of 2025.
Article content
Zetagen expects to submit an Investigation New Drug (IND) application to the U.S. Food and Drug Administration ('FDA'), leveraging its FDA's Breakthrough designations.
Article content
ZetaMet™ (Zeta-BC-003) is the first-of-its-kind, synthetic, small-molecule delivered via a proprietary controlled-release carrier intended to resolve metastatic breast cancer bone lesions, administered locoregionally, to inhibit pain while regenerating new bone, with the potential to increase survival rates.
Article content
ZetaMet's (Zeta-BC-003) small molecule mechanism of action (MOA) via a novel molecular pathway initiates a circuit which results in tumor cell death.
Article content
The US Food & Drug Administration (FDA) has recognized Zetagen's discoveries with multiple Breakthrough Designations including ZetaMet™ (Zeta-BC-003).
Article content
Zetagen with FDA and Health Canada (HC) approval via their Expanded Access (Compassionate Use) programs has treated several patients with ZetaMet™ (Zeta-BC-003) with results published in multiple peer-reviewed journals.
Article content
Peer-reviewed 2-year follow up clinical data published in 2023 on ZetaMet™ (Zeta-BC-003) demonstrated resolution of 7 lytic lesions (radiated and non-radiated), reduction in pain, significant reduction in opioid pain medication (4-fold), prevention of vertebral fracture, and increased survival rate in a patient living with Stage 4 breast cancer. To view this publication via open access, go to: https://www.tandfonline.com/doi/full/10.2217/pmt-2023-0069
Article content
Founded in 2015, Zetagen Therapeutics is a private, clinical-stage, biopharmaceutical company dedicated to developing breakthrough therapies via local administration for metastatic and primary breast cancers.
Article content
The company's 'Zeta' platform encompasses the following breast oncological drug candidates ZetaMet™ (Zeta-BC-003), ZetaMAST™ (Zeta-MBC-005) and (NEW) ZetaPrime™ (Zeta-PBC-007). To learn more, visit www.zetagen.com
Article content
Zetagen will attend the upcoming San Antonio Breast Cancer Symposium (SABCS) this December.
Article content
This press release contains certain forward-looking statements with the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act, as amended, including those relating to the Company's product development, clinical and regulatory timelines, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statements that are predictive in nature. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management's current beliefs and assumptions. Source: Zetagen Therapeutics, Inc.
Article content
Article content
Article content
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
11 minutes ago
- CTV News
B.C. regulator issues alert about alleged unlicensed property manager
B.C.'s real estate industry regulator is asking property owners in and around the province's capital for assistance in an ongoing investigation into alleged unlicensed activity by a local woman and her company. Radoslava Stoycheva and her company Victoria Royal Vacations Inc. have made an undertaking to the B.C. Financial Services Authority to immediately cease all unlicensed real estate activity, the regulator said in a consumer alert issued Tuesday. 'Rental property owners who have used Stoycheva's or VRV's services, or who have been approached by either, can contact BCFSA and share information of your interactions,' the alert reads, directing those with information to email realestate@ or use the complaints portal on the regulator's website. The alert does not elaborate on the type of real estate services Stoycheva and VRV were allegedly providing, though it does advise rental property owners who are using or considering hiring a rental property manager to verify that the person in question holds a BCFSA licence. If Stoycheva breaches her undertaking, she could personally face administrative penalties of up to $100,000 and fines of up to $250,000. Her company could be fined up to $500,000. 'BCFSA seeks the assistance of the public to understand the scope of activity that may have taken place prior to BCFSA accepting this undertaking from Radoslava Stoycheva and her company,' the alert reads. Stoycheva is the sole director of VRV, according to the BCFSA.
CTV News
11 minutes ago
- CTV News
BHP confirms 2nd phase of Jansen Mine delayed to 2031
After facing delays earlier this year – BHP now says the second phase of its Jansen potash project will be pushed back two years until 2031. The Australian mining conglomerate initially stated in July that it had moved its first production date from the mine to mid-2027 from an earlier estimate of late 2026. At that time, the company said it was also considering pushing back its second phase deadline as well – amid concerns over increased costs. On Tuesday, that decision was confirmed. 'While consumer inflation has fallen to close to two per cent in Canada, price growth for industrial construction works has been significantly stronger, increasing by over 10 per cent in the past two years in Saskatoon,' the company wrote in its annual report. 'This has placed upwards pressure on costs for Jansen.' The project, initially estimated to cost $5.7 billion USD, has now risen to a range of $7 billion to $7.4 billion USD. As of the report's publication, the mine's first stage is 68 per cent complete. Once complete, the mine will have a capacity of 4.15 Mtpa (million tons per annum). The mine's second stage, currently at 11 per cent complete, will see the development of more mining districts, expanded processing facilities and rail infrastructure to boost the mine's output inclemently to 4.36 Mtpa. According to its report, BHP expects the mine to serve as one of the industry's lowest-cost producers once production is fully ramped up. NDP calls on Moe for answers The Saskatchewan NDP called on Premier Scott Moe to speak on the project's delays – saying the mine is simply too critical to the province's economic future. 'It will be a major boost to our province, and we all want to see it succeed and want to see these good, mortgage-paying jobs for generations,' NDP MLA Trent Wotherspoon told reporters Tuesday. 'Unfortunately, this isn't the first major project to take a hit under the Sask. Party's watch.' The NDP also highlighted other large infrastructure projects that have been put on hold in recent months – including FCL's renewable diesel and canola crush facilities in addition to Viterra's canola crush plant. 'I hope he is straight with the people of Saskatchewan and answers for this string of bad economic news,' Wotherspoon added. 'Whatever the explanation, these projects are key to our province's economic future and we need answers.'
CTV News
11 minutes ago
- CTV News
Air Canada strike ends, but passengers still face long wait times
Many travellers in the Maritimes are waiting to see if their flights will take off as the Air Canada strike ends. Flight attendants say they're relieved to return to work after Air Canada reached a tentative agreement with its union, but passengers continue to face long waits and disruptions at airports. 'The phone was going absolutely crazy. We had received a stand down order at about 5:30 in the morning Halifax time,' said Lisa Vivian Macdonald, an in-charge flight attendant with Air Canada. 'We were jubilant, you know, like we were relieved. We were kind of shocked it happened pretty quickly, but maybe a little bit anxious. We don't know what's in the tentative agreement just yet, but definitely very relieved that we didn't have to go back to the picket line today.' Macdonald said one of the most significant messages filtering through was that 'unpaid work is over.' 'It's definitely one of our big two items. One is wages, the other one is unpaid work,' she said. 'Just saying those words is just such an incredible relief. It's such a good feeling that we don't have to fight this fight anymore. We can go back to doing what we really love, helping passengers in the air and on the ground, and we're going to be paid for it. That's just the best feeling. It's our perseverance really paid off in this regard.' She said fight crews were already being called back to duty. 'Our phones have been all abuzz this afternoon with the company reaching out to us, getting us back to base, people getting their uniforms on, packing their bags, heading out to the airport. From what I understand, we have four aircrafts here in Halifax, so those will be quickly crewed as soon as possible, and back in the rotation again,' she said. The Halifax Airport Authority said Air Canada is beginning the restart of its network. 'Air Canada has advised that its flight operations will restart as early as this evening, but they've also advised that that can take some time, considering it's a network-wide affected situation,' said spokesperson Jessica Pettigrew. 'They're saying it could take seven-to-10 days to get their network back to regular operations. 'Our message and advice for passengers remains the same, which is to please not come to the airport unless they've confirmed their flight status.' Some passengers at Halifax Stanfield International Airport were able to secure seats after days of uncertainty. 'My earliest flight out was going to be Saturday,' said Brooke Takacas, who had travelled to Halifax to visit her sister. 'Got a call this morning, or just saw that the strike was over this morning, and came back to the airport and tried my best to get on a flight. They're really accommodating. Most of the staff up there are trying to move you to other airports within the area, whether it be Moncton or Fredericton or St. John's because they're only flying west out here and their flights are booking up. 'I get to go home tonight. I got on a flight. 8:50 I board, so I'm feeling good.' Other travellers expressed anger over the costs they faced. ' I fortunately had the thought on Thursday, I needed to book another flight, so I booked it with Flair,' said passenger Lorraine Jack. 'Now the baggage I have is what they call an under-the-seat regulation… But I had to pay almost an extra $100 just for my little carry-on because I was quarter inch over. On top of my $350 Flair flight, I had to pay for one way to a different airport that's not even going to Toronto. 'I could have got a flight with Porter for Friday for $1,600. The big, huge problem is I have an oncology appointment tomorrow with a cancer specialist. I can't miss it. I have to do it.' She said she had heard of other passengers who have spent thousands. 'It's ridiculous the stories I'm hearing,' she said. 'Organ transplants were left sitting. Something's wrong and something's got to get fixed. 'You try to talk to Air Canada and the only thing they're offering is a refund on the unused portion of my trip, which is approximately $140, which doesn't even begin to pay for hotels, meals, the extra – well, just the flight alone. But I gotta get home. What else can I do? Thank God it's over, and hopefully we'll be back. But we need to get something that this doesn't happen. This affected thousands of people.'
